Search results
Results from the WOW.Com Content Network
Its official long title is "An Act to make new provision with respect to medicinal products and related matters, and for purposes connected therewith." [1] It governs the control of medicines for human use and for veterinary use, which includes the manufacture and supply of medicines, and the manufacture and supply of (medicated) animal feeding ...
Building of the ANSM in Paris. Agence nationale de sécurité du médicament et des produits de santé (ANSM) is a drug regulator in France.ANSM is responsible for assessing the benefits and risks associated with the use of drugs and other medical products throughout their life-cycle: it assesses the safety, efficacy and quality of these products and must balance patient safety with access to ...
[22] [23] Like most countries, France faces problems of rising costs of prescription medication, increasing unemployment, and a large aging population. [24] Expenses related to the healthcare system in France represented 10.5% of the country's GDP and 15.4% of its public expenditures. In 2004, 78.4% of these expenses were paid for by the state ...
The European Medicines Agency (EMA) operates as a decentralised scientific agency (as opposed to a regulatory authority) of the European Union (EU) and its main responsibility is the protection and promotion of public and animal health, through the evaluation and supervision of medicines for human and veterinary use. [8]
The Human Medicines Regulations 2012 in the United Kingdom were created, under statutory authority of the European Communities Act 1972 and the Medicines Act 1968 in 2012. The body responsible for their upkeep is the Medicines and Healthcare products Regulatory Agency. The regulations partially repealed the Medicines Act 1968 in line with EU ...
In 1999, the Medicines Control Agency (MCA) took over control of the General Practice Research Database (GPRD) from the Office for National Statistics. The Medicines Control Agency (MCA) and the Medical Devices Agency (MDA) merged in 2003 to form MHRA. In April 2012, the GPRD was rebranded as the Clinical Practice Research Datalink (CPRD).
The Committee on Safety of Medicines (CSM) was an independent advisory committee that advised the UK Licensing Authority on the quality, efficacy, and safety of medicines. Following the thalidomide tragedy of 1957 to 1961, in 1963 the government asked Sir Derrick Dunlop to set up a committee to investigate the control and introduction of new ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us